Suchergebnisse - "Banach, Maciej"

PubPharm (30)

1

Which Statin is Best for the Kidneys?

enthalten in: Current vascular pharmacology | 2023

von E Penson, P. | Banach, M. | McCloskey, A.

2

Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model

enthalten in: Current vascular pharmacology | 2022

von Momtazi-Borojeni, A. | Abdollahi, E. | Jaafari, M. | +3

3

Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome

enthalten in: Current vascular pharmacology | 2019

von Kidawa, M. | Gluba-Brzózka, A. | Zielinska, M. | +3

CommentIn: Curr Vasc Pharmacol. 2019;17(4):376-378. - PMID 30209992

4

High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease

enthalten in: Current vascular pharmacology | 2017

von Rysz-Gorzynska, M. | Gluba-Brzozka, A. | Banach, M.

5

The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease

enthalten in: Current vascular pharmacology | 2016

von Franczyk, B. | Gluba-Brzózka, A. | Ciałkowska-Rysz, A. | +2

6

Editorial : MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?

enthalten in: Current vascular pharmacology | 2016

von Sahebkar, A. | Maffioli, P. | Banach, M. | +1

7

Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?

enthalten in: Current vascular pharmacology | 2016

von Sahebkar, A. | Maffioli, P. | Banach, M. | +1

8

Renalase is removed by kidneys and during dialysis - excess related to CKD complications?

enthalten in: Current vascular pharmacology | 2015

von Malyszko, J. | Koc-Zorawska, E. | Zorawski, M. | +5

9

Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)

enthalten in: Current vascular pharmacology | 2014

von Ertek, S. | Banach, M.

10

Patients with Prehypertension - Do we have Enough Evidence to Treat them?

enthalten in: Current vascular pharmacology | 2014

von Marta, M. | Zanchetti, A. | D. Wong, N. | +3